Skip to main content

Lindsay Dudfield, Executive Director and CEO of Jindalee Resources Limited, Executed MOU with POSCO Holdings For Joint Research At McDermitt Lithium Project

JINDALEE RESOURCES LIMITED  (ASX: JRL) (Jindalee, the Company) is an Australian exploration company with Tier 1 lithium deposits in its portfolio in the United States. The Company’s core goals are to discover world-class mineral deposits and generate shareholder wealth. The United States is one of the largest marketplaces for lithium demand, and Jindalee is a leading company committed to help meet future demand. The Company is focussing efforts into developing its McDermitt lithium deposit. Jindalee Resources was listed on the Australian Securities Exchange (ASX) on 11th July 2002 and raised AUD 2.70 million. Now, it is a pure-play United States lithium company. Jindalee’s Projects: In June 2018, the Company acquired McDermitt and Clayton North, two lithium sediment projects in the United States. Both projects are 100% owned by HiTech Minerals Inc., a wholly owned, US-based subsidiary of Jindalee. Several factors attracted the Company’s interest in these projects including: Potenti...

Roquefort Therapeutics Reports In-Vivo Safety For Midkine Oncology Antibodies

ROQUEFORT THERAPEUTICS (LSE: ROQ, OTCQB: ROQAF) (“Roquefort” or the “Company”) ANNOUNCES that two of its Midkine (MDK) antibody programs, ROQ-A1 and ROQ-A2, demonstrate in-vivo safety in the pre-clinical development programs. The pre-clinical programs were carried out by leading cancer research groups.

ROQ-A1 and ROQ-A2 are two patented antibody medicines designed by Roquefort to target metastatic breast cancer and metastatic lung cancer. The experiments demonstrated that ROQ-A1 and ROQ-A2 bind specifically to MDK receptors in cancerous cells in the breast and lung and kill cancer in vitro.

Antibody programs targeting metastatic lung and breast cancer commenced in Q4 2022 at Olivia Newton-John Cancer Research Institute (La Trobe University), Hawkins Laboratory Biochemistry and Genetics (La Trobe University). Both antibodies have demonstrated good safety profiles validated in in-vivo models. The targets and milestones were achieved within budget and on time. 

 AJAN REGINALD, the CEO of Roquefort, said, “Roquefort focused on treatment fields with the highest unmet need. Even with the advancements in medicine in the last 30 years, some cancers are still poorly treated. Metastatic breast cancer & metastatic lung cancer have poor prognoses even with the best treatments. Overall mortality rates can be as high as 70%. That is why Midkine may be a good target, and these antibodies were engineered to target Midkine in these cancers.”

What’s Next?

ROQUEFORT will be COMMENCING EFFICACY PROGRAMS on ROQ-A1 and ROQ-A2. Efficacy programs will involve testing the efficiency of ROQ-A1 and ROQ-A2 to kill cancer by first shrinking tumours that start in the breast or lung of the patient or metastasised tumour, i.e., those tumours that usually start in either the lung or the breast and then spread to other organs.

If you’re interested in learning more about ROQUEFORT THERAPEUTICS, visit the OFFICIAL WEBSITE now.

Resource Link



Comments

Popular posts from this blog

Lindsay Dudfield, Executive Director and CEO of Jindalee Resources Limited, Executed MOU with POSCO Holdings For Joint Research At McDermitt Lithium Project

JINDALEE RESOURCES LIMITED  (ASX: JRL) (Jindalee, the Company) is an Australian exploration company with Tier 1 lithium deposits in its portfolio in the United States. The Company’s core goals are to discover world-class mineral deposits and generate shareholder wealth. The United States is one of the largest marketplaces for lithium demand, and Jindalee is a leading company committed to help meet future demand. The Company is focussing efforts into developing its McDermitt lithium deposit. Jindalee Resources was listed on the Australian Securities Exchange (ASX) on 11th July 2002 and raised AUD 2.70 million. Now, it is a pure-play United States lithium company. Jindalee’s Projects: In June 2018, the Company acquired McDermitt and Clayton North, two lithium sediment projects in the United States. Both projects are 100% owned by HiTech Minerals Inc., a wholly owned, US-based subsidiary of Jindalee. Several factors attracted the Company’s interest in these projects including: Potenti...

Platina Resources Limited signed a Joint Venture agreement with Chalice Mining for the Mt Narryer Gold Project

  PLATINA RESOURCES LIMITED  (ASX: PGM) (Platina or the Company) is a mineral resource exploration company based in Western Australia. The Company has inked a  JOINT VENTURE AGREEMENT WITH CHALICE MINING LIMITED , a mineral exploration and development company, to operate the Mt Narryer Gold Project. Terms of the Joint Venture Stage 1 earn-in : Initially, Chalice Mining will earn a  51% INTEREST  in the project by investing  AUD 600,000  within two years, which must include at least  AUD 150,000  in the first year Stage 2 earn-in : Chalice Mining can acquire an additional  24% INTEREST  in the project by investing an extra  AUD 1.8 MILLION  within the next two years Platina free cost carry : Once Chalice Mining has obtained a  75% INTEREST  in the Project, Platina Resources Limited will continue to be free cost carried until the Pre-Feasibility Study is completed Contribute & Dilute : After the Pre-Feasibility...

Jindalee Resources Limited releases half-yearly financial report for the period ended on December 31st, 2022: Important facts and figures

  JINDALEE RESOURCES LIMITED   (ASX: JRL), (Jindalee, the Company), a mineral exploration company based in Western Australia, releases its   HALF-YEARLY FINANCIAL REPORT   for the period ended on December 31 st , 2022. The Company is aligned with its goals and working on its potential projects. Also, after the reporting period, Jindalee spun off the Australian lithium, nickel, and gold assets to focus on its core assets in the United States. Operations During the Period Jindalee Resources focused on the McDermitt Lithium Project in the United States during the half-year period. Drilling was executed to expand the existing resource base along with metallurgical test work, cultural surveys, and environmental baseline studies to reduce the risks associated with the project. The Company acquired an 80% stake in the Deep Well Nickel-Copper-PGE Project (Western Australia) and divested several non-core projects there. As part of its proposed exploration for early 2023, Jind...